{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T11:58:20Z","timestamp":1774267100046,"version":"3.50.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T00:00:00Z","timestamp":1753315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T00:00:00Z","timestamp":1753315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100014823","name":"VGH and UBC Hospital Foundation","doi-asserted-by":"publisher","award":["OVCARE"],"award-info":[{"award-number":["OVCARE"]}],"id":[{"id":"10.13039\/100014823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014823","name":"VGH and UBC Hospital Foundation","doi-asserted-by":"publisher","award":["OVCARE"],"award-info":[{"award-number":["OVCARE"]}],"id":[{"id":"10.13039\/100014823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014823","name":"VGH and UBC Hospital Foundation","doi-asserted-by":"publisher","award":["OVCARE"],"award-info":[{"award-number":["OVCARE"]}],"id":[{"id":"10.13039\/100014823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014823","name":"VGH and UBC Hospital Foundation","doi-asserted-by":"publisher","award":["OVCARE"],"award-info":[{"award-number":["OVCARE"]}],"id":[{"id":"10.13039\/100014823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014823","name":"VGH and UBC Hospital Foundation","doi-asserted-by":"publisher","award":["OVCARE"],"award-info":[{"award-number":["OVCARE"]}],"id":[{"id":"10.13039\/100014823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-178179"],"award-info":[{"award-number":["PJT-178179"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-178179"],"award-info":[{"award-number":["PJT-178179"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-178179"],"award-info":[{"award-number":["PJT-178179"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-178179"],"award-info":[{"award-number":["PJT-178179"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-178179"],"award-info":[{"award-number":["PJT-178179"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-178179"],"award-info":[{"award-number":["PJT-178179"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000521","name":"Canadian Cancer Society","doi-asserted-by":"publisher","award":["Research Training Award"],"award-info":[{"award-number":["Research Training Award"]}],"id":[{"id":"10.13039\/501100000521","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Canadian Graduate Scholarship","award":["Master's program"],"award-info":[{"award-number":["Master's program"]}]},{"name":"Canadian Graduate Scholarship","award":["Master's program"],"award-info":[{"award-number":["Master's program"]}]},{"name":"Canadian Graduate Scholarship","award":["Master's program"],"award-info":[{"award-number":["Master's program"]}]},{"DOI":"10.13039\/501100004376","name":"Terry Fox Research Institute","doi-asserted-by":"publisher","award":["PPG #1116"],"award-info":[{"award-number":["PPG #1116"]}],"id":[{"id":"10.13039\/501100004376","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004376","name":"Terry Fox Research Institute","doi-asserted-by":"publisher","award":["PPG #1116"],"award-info":[{"award-number":["PPG #1116"]}],"id":[{"id":"10.13039\/501100004376","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004376","name":"Terry Fox Research Institute","doi-asserted-by":"publisher","award":["PPG #1116"],"award-info":[{"award-number":["PPG #1116"]}],"id":[{"id":"10.13039\/501100004376","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004376","name":"Terry Fox Research Institute","doi-asserted-by":"publisher","award":["PPG #1116"],"award-info":[{"award-number":["PPG #1116"]}],"id":[{"id":"10.13039\/501100004376","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["RGPIN-2020-05390"],"award-info":[{"award-number":["RGPIN-2020-05390"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Precis. Onc."],"DOI":"10.1038\/s41698-025-01053-x","type":"journal-article","created":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T09:46:02Z","timestamp":1753350362000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Molecular subtyping of endometrial carcinoma cell lines uncovers subtype-specific targetable vulnerabilities"],"prefix":"10.1038","volume":"9","author":[{"given":"Eunice S.","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ran","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yannes Wai Yan","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chae Young","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shary Y.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bengul","family":"Gokbayrak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janine","family":"Senz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Betty","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liam","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Spencer D.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark S.","family":"Carey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryan T.","family":"Hennessy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David G.","family":"Huntsman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramon I.","family":"Klein Geltink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynn","family":"Hoang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yemin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,24]]},"reference":[{"key":"1053_CR1","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1200\/JCO.2012.48.2596","volume":"31","author":"VW Setiawan","year":"2013","unstructured":"Setiawan, V. W. et al. Type I and II endometrial cancers: have they different risk factors? J. Clin. Oncol. 31, 2607\u20132618 (2013).","journal-title":"J. Clin. Oncol."},{"key":"1053_CR2","doi-asserted-by":"crossref","unstructured":"Cancer et al. Integrated genomic characterization of endometrial carcinoma. Nature 497, 67\u201373 (2013).","DOI":"10.1038\/nature12113"},{"key":"1053_CR3","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/path.4056","volume":"228","author":"MK McConechy","year":"2012","unstructured":"McConechy, M. K. et al. Use of mutation profiles to refine the classification of endometrial carcinomas. J. Pathol. 228, 20\u201330 (2012).","journal-title":"J. Pathol."},{"key":"1053_CR4","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.3892\/ol.2017.6640","volume":"14","author":"H Kunitomi","year":"2017","unstructured":"Kunitomi, H. et al. New use of microsatellite instability analysis in endometrial cancer. Oncol. Lett. 14, 3297\u20133301 (2017).","journal-title":"Oncol. Lett."},{"key":"1053_CR5","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1093\/annonc\/mdy058","volume":"29","author":"S Kommoss","year":"2018","unstructured":"Kommoss, S. et al. Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series. Ann. Oncol. 29, 1180\u20131188 (2018).","journal-title":"Ann. Oncol."},{"key":"1053_CR6","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1002\/cncr.30496","volume":"123","author":"A Talhouk","year":"2017","unstructured":"Talhouk, A. et al. Confirmation of ProMisE: A simple, genomics-based clinical classifier for endometrial cancer. Cancer 123, 802\u2013813 (2017).","journal-title":"Cancer"},{"key":"1053_CR7","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1136\/ijgc-2020-002230","volume":"31","author":"N Concin","year":"2021","unstructured":"Concin, N. et al. ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma. Int. J. Gynecol. Cancer 31, 12\u201339 (2021).","journal-title":"Int. J. Gynecol. Cancer"},{"key":"1053_CR8","doi-asserted-by":"publisher","unstructured":"Leon-Castillo, A. et al. Clinicopathological and molecular characterisation of \u2018multiple-classifier\u2019 endometrial carcinomas. J. Pathol. https:\/\/doi.org\/10.1002\/path.5373 (2019).","DOI":"10.1002\/path.5373"},{"key":"1053_CR9","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1136\/ijgc-2020-002256","volume":"31","author":"A Jamieson","year":"2021","unstructured":"Jamieson, A., Thompson, E. F., Huvila, J., Gilks, C. B. & McAlpine, J. N. p53abn Endometrial Cancer: understanding the most aggressive endometrial cancers in the era of molecular classification. Int. J. Gynecol. Cancer 31, 907\u2013913 (2021).","journal-title":"Int. J. Gynecol. Cancer"},{"key":"1053_CR10","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1038\/s41591-025-03566-1","volume":"31","author":"RN Eskander","year":"2025","unstructured":"Eskander, R. N. et al. Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trial. Nat. Med. 31, 1539\u20131546 (2025).","journal-title":"Nat. Med."},{"key":"1053_CR11","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2024.35.e40","volume":"35","author":"K Yonemori","year":"2024","unstructured":"Yonemori, K. et al. Analysis of East Asia subgroup in Study 309\/KEYNOTE-775: lenvatinib plus pembrolizumab versus treatment of physician\u2019s choice chemotherapy in patients with previously treated advanced or recurrent endometrial cancer. J. Gynecol. Oncol. 35, e40 (2024).","journal-title":"J. Gynecol. Oncol."},{"key":"1053_CR12","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1097\/01.pgp.0000183048.22588.18","volume":"25","author":"EG Silva","year":"2006","unstructured":"Silva, E. G., Deavers, M. T., Bodurka, D. C. & Malpica, A. Association of low-grade endometrioid carcinoma of the uterus and ovary with undifferentiated carcinoma: a new type of dedifferentiated carcinoma? Int. J. Gynecol. Pathol. 25, 52\u201358 (2006).","journal-title":"Int. J. Gynecol. Pathol."},{"key":"1053_CR13","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1097\/PAS.0000000000000166","volume":"38","author":"E Kuhn","year":"2014","unstructured":"Kuhn, E., Ayhan, A., Bahadirli-Talbott, A., Zhao, C. & Shih Ie, M. Molecular characterization of undifferentiated carcinoma associated with endometrioid carcinoma. Am. J. Surg. Pathol. 38, 660\u2013665 (2014).","journal-title":"Am. J. Surg. Pathol."},{"key":"1053_CR14","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/modpathol.2010.41","volume":"23","author":"LJ Tafe","year":"2010","unstructured":"Tafe, L. J., Garg, K., Chew, I., Tornos, C. & Soslow, R. A. Endometrial and ovarian carcinomas with undifferentiated components: clinically aggressive and frequently underrecognized neoplasms. Mod. Pathol. 23, 781\u2013789 (2010).","journal-title":"Mod. Pathol."},{"key":"1053_CR15","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1111\/his.14186","volume":"77","author":"A Busca","year":"2020","unstructured":"Busca, A. et al. Undifferentiated endometrial carcinoma arising in the background of high-grade endometrial carcinoma - Expanding the definition of dedifferentiated endometrial carcinoma. Histopathology 77, 769\u2013780 (2020).","journal-title":"Histopathology"},{"key":"1053_CR16","doi-asserted-by":"publisher","unstructured":"Karnezis, A. N. et al. Re-assigning the histologic identities of COV434 and TOV-112D ovarian cancer cell lines. Gynecol. Oncol., https:\/\/doi.org\/10.1016\/j.ygyno.2020.12.004 (2020).","DOI":"10.1016\/j.ygyno.2020.12.004"},{"key":"1053_CR17","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1080\/00313020601159494","volume":"39","author":"EG Silva","year":"2007","unstructured":"Silva, E. G., Deavers, M. T. & Malpica, A. Undifferentiated carcinoma of the endometrium: a review. Pathology 39, 134\u2013138 (2007).","journal-title":"Pathology"},{"key":"1053_CR18","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1097\/PAT.0000000000000270","volume":"47","author":"CJ Stewart","year":"2015","unstructured":"Stewart, C. J. & Crook, M. L. SWI\/SNF complex deficiency and mismatch repair protein expression in undifferentiated and dedifferentiated endometrial carcinoma. Pathology 47, 439\u2013445 (2015).","journal-title":"Pathology"},{"key":"1053_CR19","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1038\/modpathol.2016.156","volume":"29","author":"M Coatham","year":"2016","unstructured":"Coatham, M. et al. Concurrent ARID1A and ARID1B inactivation in endometrial and ovarian dedifferentiated carcinomas. Mod. Pathol. 29, 1586\u20131593 (2016).","journal-title":"Mod. Pathol."},{"key":"1053_CR20","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1097\/PAS.0000000000000941","volume":"42","author":"M Kobel","year":"2018","unstructured":"Kobel, M. et al. Undifferentiated endometrial carcinomas show frequent loss of core switch\/sucrose nonfermentable complex proteins. Am. J. Surg. Pathol. 42, 76\u201383 (2018).","journal-title":"Am. J. Surg. Pathol."},{"key":"1053_CR21","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.anndiagpath.2015.04.001","volume":"19","author":"JD Strehl","year":"2015","unstructured":"Strehl, J. D. et al. Pattern of SMARCB1 (INI1) and SMARCA4 (BRG1) in poorly differentiated endometrioid adenocarcinoma of the uterus: analysis of a series with emphasis on a novel SMARCA4-deficient dedifferentiated rhabdoid variant. Ann. Diagn. Pathol. 19, 198\u2013202 (2015).","journal-title":"Ann. Diagn. Pathol."},{"key":"1053_CR22","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1002\/cjp2.188","volume":"7","author":"B Tessier-Cloutier","year":"2021","unstructured":"Tessier-Cloutier, B. et al. SWI\/SNF-deficiency defines highly aggressive undifferentiated endometrial carcinoma. J. Pathol. Clin. Res. 7, 144\u2013153 (2021).","journal-title":"J. Pathol. Clin. Res."},{"key":"1053_CR23","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.ygyno.2021.02.029","volume":"161","author":"A Santoro","year":"2021","unstructured":"Santoro, A. et al. Clinico-pathological significance of TCGA classification and SWI\/SNF proteins expression in undifferentiated\/dedifferentiated endometrial carcinoma: a possible prognostic risk stratification. Gynecol. Oncol. 161, 629\u2013635 (2021).","journal-title":"Gynecol. Oncol."},{"key":"1053_CR24","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1158\/1078-0432.CCR-23-3689","volume":"30","author":"A Jamieson","year":"2024","unstructured":"Jamieson, A. et al. Targeted and shallow whole-genome sequencing identifies therapeutic opportunities in p53abn endometrial cancers. Clin. Cancer Res. 30, 2461\u20132474 (2024).","journal-title":"Clin. Cancer Res."},{"key":"1053_CR25","doi-asserted-by":"publisher","first-page":"e1009986","DOI":"10.1371\/journal.pgen.1009986","volume":"17","author":"JJ Reske","year":"2021","unstructured":"Reske, J. J. et al. Co-existing TP53 and ARID1A mutations promote aggressive endometrial tumorigenesis. PLoS Genet. 17, e1009986 (2021).","journal-title":"PLoS Genet."},{"key":"1053_CR26","doi-asserted-by":"publisher","unstructured":"Shin, C. Y. et al. Prognostic values of molecular subtypes and SWI\/SNF protein expression in de-differentiated\/undifferentiated endometrial carcinoma. Histopathology, https:\/\/doi.org\/10.1111\/his.15411 (2025).","DOI":"10.1111\/his.15411"},{"key":"1053_CR27","doi-asserted-by":"publisher","first-page":"e0240412","DOI":"10.1371\/journal.pone.0240412","volume":"15","author":"Y Wang","year":"2020","unstructured":"Wang, Y. et al. Establishment and characterization of VOA1066 cells: An undifferentiated endometrial carcinoma cell line. PLoS ONE 15, e0240412 (2020).","journal-title":"PLoS ONE"},{"key":"1053_CR28","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/s43018-020-00109-0","volume":"1","author":"Z Wang","year":"2020","unstructured":"Wang, Z. et al. Dual ARID1A\/ARID1B loss leads to rapid carcinogenesis and disruptive redistribution of BAF complexes. Nat. Cancer 1, 909\u2013922 (2020).","journal-title":"Nat. Cancer"},{"key":"1053_CR29","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1006\/gyno.1994.1191","volume":"54","author":"Y Hirai","year":"1994","unstructured":"Hirai, Y., Kawaguchi, T., Hasumi, K., Kitagawa, T. & Noda, T. Establishment and characterization of human cell lines from a serous papillary adenocarcinoma of the endometrium. Gynecol. Oncol. 54, 184\u2013195 (1994).","journal-title":"Gynecol. Oncol."},{"key":"1053_CR30","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1111\/j.1749-6632.1991.tb37884.x","volume":"622","author":"H Kuramoto","year":"1991","unstructured":"Kuramoto, H. et al. Establishment and characterization of human endometrial cancer cell lines. Ann. N. Y. Acad. Sci. 622, 402\u2013421 (1991).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"1053_CR31","first-page":"199","volume":"10","author":"H Fushiki","year":"1997","unstructured":"Fushiki, H. et al. Characterization of a newly established human tumor cell line (TEN) from a patient with clear cell carcinoma of the uterine body and its sensitivity to anti-cancer agents. Hum. Cell 10, 199\u2013208 (1997).","journal-title":"Hum. Cell"},{"key":"1053_CR32","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/s41586-019-1102-x","volume":"568","author":"EM Chan","year":"2019","unstructured":"Chan, E. M. et al. WRN helicase is a synthetic lethal target in microsatellite unstable cancers. Nature 568, 551\u2013556 (2019).","journal-title":"Nature"},{"key":"1053_CR33","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s43018-023-00699-5","volume":"5","author":"M Payton","year":"2024","unstructured":"Payton, M. et al. Small-molecule inhibition of kinesin KIF18A reveals a mitotic vulnerability enriched in chromosomally unstable cancers. Nat. Cancer 5, 66\u201384 (2024).","journal-title":"Nat. Cancer"},{"key":"1053_CR34","doi-asserted-by":"publisher","first-page":"3254","DOI":"10.1002\/1873-3468.12366","volume":"590","author":"K Ikeuchi","year":"2016","unstructured":"Ikeuchi, K., Yazaki, E., Kudo, K. & Inada, T. Conserved functions of human Pelota in mRNA quality control of nonstop mRNA. FEBS Lett. 590, 3254\u20133263 (2016).","journal-title":"FEBS Lett."},{"key":"1053_CR35","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1093\/jnci\/59.1.221","volume":"59","author":"J Fogh","year":"1977","unstructured":"Fogh, J., Fogh, J. M. & Orfeo, T. One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. J. Natl. Cancer Inst. 59, 221\u2013226 (1977).","journal-title":"J. Natl. Cancer Inst."},{"key":"1053_CR36","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1097\/PGP.0000000000001010","volume":"43","author":"J Huvila","year":"2024","unstructured":"Huvila, J. et al. Endometrial carcinosarcomas are almost exclusively of p53abn molecular subtype after exclusion of mimics. Int. J. Gynecol. Pathol. 43, 506\u2013514 (2024).","journal-title":"Int. J. Gynecol. Pathol."},{"key":"1053_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38594-3","volume":"14","author":"X Zhu","year":"2023","unstructured":"Zhu, X. et al. Alanine supplementation exploits glutamine dependency induced by SMARCA4\/2-loss. Nat. Commun. 14, 2894 (2023).","journal-title":"Nat. Commun."},{"key":"1053_CR38","doi-asserted-by":"publisher","first-page":"7481","DOI":"10.1074\/jbc.RA120.013366","volume":"295","author":"A Tsuji","year":"2020","unstructured":"Tsuji, A., Akao, T., Masuya, T., Murai, M. & Miyoshi, H. IACS-010759, a potent inhibitor of glycolysis-deficient hypoxic tumor cells, inhibits mitochondrial respiratory complex I through a unique mechanism. J. Biol. Chem. 295, 7481\u20137491 (2020).","journal-title":"J. Biol. Chem."},{"key":"1053_CR39","doi-asserted-by":"publisher","unstructured":"Borck, P. C. et al. SKI complex loss renders 9p21.3-deleted or MSI-H cancers dependent on PELO. Nature, https:\/\/doi.org\/10.1038\/s41586-024-08509-3 (2025).","DOI":"10.1038\/s41586-024-08509-3"},{"key":"1053_CR40","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1038\/emboj.2011.93","volume":"30","author":"VP Pisareva","year":"2011","unstructured":"Pisareva, V. P., Skabkin, M. A., Hellen, C. U., Pestova, T. V. & Pisarev, A. V. Dissociation by Pelota, Hbs1 and ABCE1 of mammalian vacant 80S ribosomes and stalled elongation complexes. EMBO J. 30, 1804\u20131817 (2011).","journal-title":"EMBO J."},{"key":"1053_CR41","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1016\/j.molcel.2020.01.011","volume":"77","author":"A Zinoviev","year":"2020","unstructured":"Zinoviev, A., Ayupov, R. K., Abaeva, I. S., Hellen, C. U. T. & Pestova, T. V. Extraction of mRNA from stalled ribosomes by the Ski complex. Mol. Cell 77, 1340\u20131349.e1346 (2020).","journal-title":"Mol. Cell"},{"key":"1053_CR42","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/ng845","volume":"30","author":"J Falck","year":"2002","unstructured":"Falck, J., Petrini, J. H., Williams, B. R., Lukas, J. & Bartek, J. The DNA damage-dependent intra-S phase checkpoint is regulated by parallel pathways. Nat. Genet. 30, 290\u2013294 (2002).","journal-title":"Nat. Genet."},{"key":"1053_CR43","doi-asserted-by":"publisher","first-page":"6685","DOI":"10.1158\/0008-5472.CAN-07-0495","volume":"67","author":"JS Myers","year":"2007","unstructured":"Myers, J. S., Zhao, R., Xu, X., Ham, A. J. & Cortez, D. Cyclin-dependent kinase 2 dependent phosphorylation of ATRIP regulates the G2-M checkpoint response to DNA damage. Cancer Res. 67, 6685\u20136690 (2007).","journal-title":"Cancer Res."},{"key":"1053_CR44","doi-asserted-by":"publisher","first-page":"e1000863","DOI":"10.1371\/journal.pgen.1000863","volume":"6","author":"JH Chung","year":"2010","unstructured":"Chung, J. H. & Bunz, F. Cdk2 is required for p53-independent G2\/M checkpoint control. PLoS Genet. 6, e1000863 (2010).","journal-title":"PLoS Genet."},{"key":"1053_CR45","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1158\/1541-7786.MCR-14-0163","volume":"13","author":"H Zalzali","year":"2015","unstructured":"Zalzali, H. et al. CDK2 transcriptional repression is an essential effector in p53-dependent cellular senescence-implications for therapeutic intervention. Mol. Cancer Res. 13, 29\u201340 (2015).","journal-title":"Mol. Cancer Res."},{"key":"1053_CR46","doi-asserted-by":"publisher","DOI":"10.1093\/narcan\/zcad039","volume":"5","author":"VE Brown","year":"2023","unstructured":"Brown, V. E. et al. CDK2 regulates collapsed replication fork repair in CCNE1-amplified ovarian cancer cells via homologous recombination. NAR Cancer 5, zcad039 (2023).","journal-title":"NAR Cancer"},{"key":"1053_CR47","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.devcel.2007.11.014","volume":"14","author":"J Stumpff","year":"2008","unstructured":"Stumpff, J., von Dassow, G., Wagenbach, M., Asbury, C. & Wordeman, L. The kinesin-8 motor Kif18A suppresses kinetochore movements to control mitotic chromosome alignment. Dev. Cell 14, 252\u2013262 (2008).","journal-title":"Dev. Cell"},{"key":"1053_CR48","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41586-020-03133-3","volume":"590","author":"RJ Quinton","year":"2021","unstructured":"Quinton, R. J. et al. Whole-genome doubling confers unique genetic vulnerabilities on tumour cells. Nature 590, 492\u2013497 (2021).","journal-title":"Nature"},{"key":"1053_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21447-2","volume":"12","author":"C Marquis","year":"2021","unstructured":"Marquis, C. et al. Chromosomally unstable tumor cells specifically require KIF18A for proliferation. Nat. Commun. 12, 1213 (2021).","journal-title":"Nat. Commun."},{"key":"1053_CR50","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41586-020-03114-6","volume":"590","author":"Y Cohen-Sharir","year":"2021","unstructured":"Cohen-Sharir, Y. et al. Aneuploidy renders cancer cells vulnerable to mitotic checkpoint inhibition. Nature 590, 486\u2013491 (2021).","journal-title":"Nature"},{"key":"1053_CR51","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.ygyno.2023.07.016","volume":"176","author":"NKY Wong","year":"2023","unstructured":"Wong, N. K. Y. et al. Establishment and validation of preclinical models of SMARCA4-inactivated and ARID1A\/ARID1B co-inactivated dedifferentiated endometrial carcinoma. Gynecol. Oncol. 176, 162\u2013172 (2023).","journal-title":"Gynecol. Oncol."},{"key":"1053_CR52","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41591-022-02103-8","volume":"29","author":"TA Yap","year":"2023","unstructured":"Yap, T. A. et al. Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials. Nat. Med. 29, 115\u2013126 (2023).","journal-title":"Nat. Med."},{"key":"1053_CR53","doi-asserted-by":"publisher","unstructured":"Villafranca-Magdalena, B. et al. Genomic validation of endometrial cancer patient-derived xenograft models as a preclinical tool. Int. J. Mol. Sc. 23, https:\/\/doi.org\/10.3390\/ijms23116266 (2022).","DOI":"10.3390\/ijms23116266"},{"key":"1053_CR54","doi-asserted-by":"publisher","first-page":"527","DOI":"10.3892\/or.2012.1807","volume":"28","author":"Y Gao","year":"2012","unstructured":"Gao, Y., Liu, T., Cheng, W. & Wang, H. Isolation and characterization of proliferative, migratory and multidrug-resistant endometrial carcinoma-initiating cells from human type II endometrial carcinoma cell lines. Oncol. Rep. 28, 527\u2013532 (2012).","journal-title":"Oncol. Rep."},{"key":"1053_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-752","volume":"14","author":"ER Theisen","year":"2014","unstructured":"Theisen, E. R. et al. Reversible inhibition of lysine specific demethylase 1 is a novel anti-tumor strategy for poorly differentiated endometrial carcinoma. BMC Cancer 14, 752 (2014).","journal-title":"BMC Cancer"},{"key":"1053_CR56","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.7150\/jca.29738","volume":"10","author":"Y Wang","year":"2019","unstructured":"Wang, Y. et al. Ellagic acid exerts antitumor effects via the PI3K signaling pathway in endometrial cancer. J. Cancer 10, 3303\u20133314 (2019).","journal-title":"J. Cancer"},{"key":"1053_CR57","doi-asserted-by":"publisher","first-page":"D980","DOI":"10.1093\/nar\/gkt1113","volume":"42","author":"MJ Landrum","year":"2014","unstructured":"Landrum, M. J. et al. ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res. 42, D980\u2013D985 (2014).","journal-title":"Nucleic Acids Res."},{"key":"1053_CR58","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41586-023-06045-0","volume":"625","author":"S Chen","year":"2024","unstructured":"Chen, S. et al. A genomic mutational constraint map using variation in 76,156 human genomes. Nature 625, 92\u2013100 (2024).","journal-title":"Nature"},{"key":"1053_CR59","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/nmeth.3047","volume":"11","author":"NE Sanjana","year":"2014","unstructured":"Sanjana, N. E., Shalem, O. & Zhang, F. Improved vectors and genome-wide libraries for CRISPR screening. Nat. Methods 11, 783\u2013784 (2014).","journal-title":"Nat. Methods"}],"container-title":["npj Precision Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41698-025-01053-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-025-01053-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-025-01053-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T23:06:13Z","timestamp":1757286373000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41698-025-01053-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,24]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1053"],"URL":"https:\/\/doi.org\/10.1038\/s41698-025-01053-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6536216\/v1","asserted-by":"object"}]},"ISSN":["2397-768X"],"issn-type":[{"value":"2397-768X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,24]]},"assertion":[{"value":"26 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"254"}}